Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
2 Acute myeloid leukemia 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
3 Adherens junction 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
4 Adherens junction 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
5 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
6 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
7 Adipocytokine signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
8 Adipocytokine signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
9 Adrenergic signaling in cardiomyocytes 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin 2件: 57, 67 💬
10 Adrenergic signaling in cardiomyocytes 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin 2件: 57, 67 💬
11 Adrenergic signaling in cardiomyocytes 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
12 Adrenergic signaling in cardiomyocytes 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
13 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
14 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
15 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
16 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
17 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
18 Adrenergic signaling in cardiomyocytes 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
19 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
20 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
21 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
22 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
23 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
24 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
25 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
26 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
27 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
28 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
29 Alcoholic liver disease 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
30 Alcoholic liver disease 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
31 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
32 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
33 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
34 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
35 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
36 Aldosterone synthesis and secretion 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
37 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
38 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
39 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
40 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
41 Aldosterone-regulated sodium reabsorption 💬
 1件: NR3C2 💬 D00443 💬 Spironolactone 7件: 58, 67, 86, 113, 210, 218, 225 💬
42 Aldosterone-regulated sodium reabsorption 💬
 3件: SCNN1A, SCNN1B, SCNN1G 💬 D00649 💬 Amiloride 4件: 13, 67, 225, 299 💬
43 Aldosterone-regulated sodium reabsorption 💬
 3件: SCNN1A, SCNN1B, SCNN1G 💬 D07447 💬 Amiloride 4件: 13, 67, 225, 299 💬
44 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
45 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
46 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
47 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
48 Alzheimer disease 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
49 Alzheimer disease 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
50 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
51 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
52 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
53 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D01173 💬 Cilnidipine 1件: 67 💬
54 AMPK signaling pathway 💬
 1件: ADRA1A 💬 D00608 💬 Doxazosin 2件: 57, 67 💬
55 AMPK signaling pathway 💬
 1件: ADRA1A 💬 D07874 💬 Doxazosin 2件: 57, 67 💬
56 AMPK signaling pathway 💬
 1件: HMGCR 💬 D00893 💬 Pravastatin 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
57 AMPK signaling pathway 💬
 1件: HMGCR 💬 D08410 💬 Pravastatin 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
58 AMPK signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
59 AMPK signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
60 AMPK signaling pathway 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
61 AMPK signaling pathway 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
62 AMPK signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
63 AMPK signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
64 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
65 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
66 Apelin signaling pathway 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
67 Apelin signaling pathway 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
68 Apelin signaling pathway 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
69 Apelin signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
70 Apelin signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
71 Apelin signaling pathway 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
72 Apelin signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
73 Apelin signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
74 Apelin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
75 Apelin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
76 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
77 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
78 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
79 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
80 Autophagy - animal 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
81 Autophagy - animal 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
82 Autophagy - animal 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
83 Autophagy - animal 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
84 Autophagy - other 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
85 Autophagy - other 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
86 Axon guidance 💬
 2件: ABL1, SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
87 Axon guidance 💬
 1件: EPHB4 💬 D11772 💬 Tesevatinib 1件: 67 💬
88 Bacterial invasion of epithelial cells 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
89 beta-Alanine metabolism 💬
 1件: AOC3 💬 D08044 💬 Hydralazine 1件: 67 💬
90 Bile secretion 💬
 1件: HMGCR 💬 D00893 💬 Pravastatin 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
91 Bile secretion 💬
 1件: HMGCR 💬 D08410 💬 Pravastatin 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
92 Bile secretion 💬
 1件: NR1H4 💬 D00734 💬 Ursodeoxycholic acid 14件:  6 ,  8 , 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬
93 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
94 Bladder cancer 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
95 Breast cancer 💬
 3件: EGFR, ERBB2, FLT4 💬 D11772 💬 Tesevatinib 1件: 67 💬
96 Breast cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
97 Breast cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
98 C-type lectin receptor signaling pathway 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
99 Calcium signaling pathway 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin 2件: 57, 67 💬
100 Calcium signaling pathway 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin 2件: 57, 67 💬
101 Calcium signaling pathway 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
102 Calcium signaling pathway 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
103 Calcium signaling pathway 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
104 Calcium signaling pathway 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
105 Calcium signaling pathway 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
106 Calcium signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
107 Calcium signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
108 Calcium signaling pathway 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
109 Calcium signaling pathway 💬
 5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
110 Calcium signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
111 Calcium signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
112 Calcium signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
113 Calcium signaling pathway 💬
 4件: EGFR, ERBB2, FLT4, KDR 💬 D11772 💬 Tesevatinib 1件: 67 💬
114 cAMP signaling pathway 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
115 cAMP signaling pathway 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
116 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
117 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
118 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
119 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
120 cAMP signaling pathway 💬
 3件: SSTR1, SSTR2, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
121 cAMP signaling pathway 💬
 3件: SSTR1, SSTR2, SSTR5 💬 D07431 💬 Somatostatin 2件: 67, 78 💬
122 cAMP signaling pathway 💬
 1件: SSTR2 💬 D00442 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
123 cAMP signaling pathway 💬
 1件: SSTR2 💬 D06495 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
124 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
125 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
126 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
127 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D01173 💬 Cilnidipine 1件: 67 💬
128 Carbohydrate digestion and absorption 💬
 2件: TAS1R2, TAS1R3 💬 D02381 💬 Aspartame 5件:  6 , 13, 67, 86, 230 💬
129 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
130 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
131 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
132 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
133 Cell cycle 💬
 1件: ABL1 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
134 Cellular senescence 💬
 1件: CACNA1D 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
135 Cellular senescence 💬
 1件: CACNA1D 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
136 Cellular senescence 💬
 1件: CACNA1D 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
137 Cellular senescence 💬
 1件: CACNA1D 💬 D01173 💬 Cilnidipine 1件: 67 💬
138 Cellular senescence 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
139 Cellular senescence 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
140 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
141 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
142 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
143 cGMP-PKG signaling pathway 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin 2件: 57, 67 💬
144 cGMP-PKG signaling pathway 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin 2件: 57, 67 💬
145 cGMP-PKG signaling pathway 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
146 cGMP-PKG signaling pathway 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
147 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
148 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
149 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
150 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
151 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
152 cGMP-PKG signaling pathway 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
153 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
154 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
155 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
156 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
157 Chagas disease 💬
 1件: ACE 💬 D08068 💬 Imidapril 1件: 67 💬
158 Chagas disease 💬
 1件: ACE 💬 D00362 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
159 Chagas disease 💬
 1件: ACE 💬 D08131 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
160 Chagas disease 💬
 1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
161 Chemical carcinogenesis - reactive oxygen species 💬
 2件: ABL1, SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
162 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
163 Chemical carcinogenesis - receptor activation 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
164 Chemical carcinogenesis - receptor activation 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
165 Chemical carcinogenesis - receptor activation 💬
 5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
166 Chemical carcinogenesis - receptor activation 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
167 Chemical carcinogenesis - receptor activation 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
168 Chemical carcinogenesis - receptor activation 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
169 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
170 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
171 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
172 Chemical carcinogenesis - receptor activation 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
173 Chemokine signaling pathway 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
174 Choline metabolism in cancer 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
175 Choline metabolism in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
176 Choline metabolism in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
177 Cholinergic synapse 💬
 5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
178 Cholinergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
179 Cholinergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
180 Cholinergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
181 Chronic myeloid leukemia 💬
 1件: ABL1 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
182 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
183 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
184 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
185 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D01173 💬 Cilnidipine 1件: 67 💬
186 Circadian rhythm 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
187 Circadian rhythm 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
188 Colorectal cancer 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
189 Colorectal cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
190 Colorectal cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
191 Coronavirus disease - COVID-19 💬
 1件: ACE 💬 D08068 💬 Imidapril 1件: 67 💬
192 Coronavirus disease - COVID-19 💬
 1件: ACE 💬 D00362 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
193 Coronavirus disease - COVID-19 💬
 1件: ACE 💬 D08131 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
194 Coronavirus disease - COVID-19 💬
 1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
195 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
196 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
197 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
198 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
199 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
200 Coronavirus disease - COVID-19 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
201 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
202 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
203 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
204 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
205 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
206 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
207 Cortisol synthesis and secretion 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
208 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
209 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
210 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
211 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
212 Cushing syndrome 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
213 Cushing syndrome 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
214 Cushing syndrome 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
215 Cushing syndrome 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
216 Cushing syndrome 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
217 Cushing syndrome 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
218 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
219 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
220 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
221 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
222 Cushing syndrome 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
223 Diabetic cardiomyopathy 💬
 1件: ACE 💬 D08068 💬 Imidapril 1件: 67 💬
224 Diabetic cardiomyopathy 💬
 1件: ACE 💬 D00362 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
225 Diabetic cardiomyopathy 💬
 1件: ACE 💬 D08131 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
226 Diabetic cardiomyopathy 💬
 1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
227 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
228 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
229 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
230 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
231 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
232 Diabetic cardiomyopathy 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
233 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
234 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
235 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
236 Dilated cardiomyopathy 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
237 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
238 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
239 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
240 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
241 Dopaminergic synapse 💬
 3件: CACNA1B, CACNA1C, CACNA1D 💬 D01173 💬 Cilnidipine 1件: 67 💬
242 Dopaminergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
243 Dopaminergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
244 Dopaminergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
245 EGFR tyrosine kinase inhibitor resistance 💬
 3件: EGFR, ERBB2, KDR 💬 D11772 💬 Tesevatinib 1件: 67 💬
246 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
247 EGFR tyrosine kinase inhibitor resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
248 EGFR tyrosine kinase inhibitor resistance 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
249 Endocrine resistance 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
250 Endocrine resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
251 Endocrine resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
252 Endocrine resistance 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
253 Endocytosis 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
254 Endocytosis 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
255 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
256 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
257 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
258 ErbB signaling pathway 💬
 2件: ABL1, SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
259 ErbB signaling pathway 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
260 ErbB signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
261 ErbB signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
262 Estrogen signaling pathway 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
263 Estrogen signaling pathway 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
264 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 D11772 💬 Tesevatinib 1件: 67 💬
265 Fluid shear stress and atherosclerosis 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
266 Fluid shear stress and atherosclerosis 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
267 Fluid shear stress and atherosclerosis 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
268 Focal adhesion 💬
 4件: EGFR, ERBB2, FLT4, KDR 💬 D11772 💬 Tesevatinib 1件: 67 💬
269 Focal adhesion 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
270 FoxO signaling pathway 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
271 FoxO signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
272 FoxO signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
273 GABAergic synapse 💬
 5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
274 GABAergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
275 GABAergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
276 GABAergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
277 GABAergic synapse 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
278 Gap junction 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
279 Gap junction 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
280 Gap junction 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
281 Gap junction 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
282 Gastric acid secretion 💬
 1件: SSTR2 💬 D00442 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
283 Gastric acid secretion 💬
 1件: SSTR2 💬 D06495 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
284 Gastric acid secretion 💬
 1件: SSTR2 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
285 Gastric acid secretion 💬
 1件: SSTR2 💬 D07431 💬 Somatostatin 2件: 67, 78 💬
286 Gastric cancer 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
287 Gastric cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
288 Gastric cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
289 Glioma 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
290 Glioma 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
291 Glioma 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
292 Glucagon signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
293 Glucagon signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
294 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
295 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
296 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
297 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D01173 💬 Cilnidipine 1件: 67 💬
298 Glycine, serine and threonine metabolism 💬
 1件: AOC3 💬 D08044 💬 Hydralazine 1件: 67 💬
299 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
300 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
301 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
302 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
303 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
304 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
305 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
306 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
307 GnRH signaling pathway 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
308 GnRH signaling pathway 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
309 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
310 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
311 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
312 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
313 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
314 Growth hormone synthesis, secretion and action 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
315 Growth hormone synthesis, secretion and action 💬
 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
316 Growth hormone synthesis, secretion and action 💬
 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 D07431 💬 Somatostatin 2件: 67, 78 💬
317 Growth hormone synthesis, secretion and action 💬
 1件: SSTR2 💬 D00442 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
318 Growth hormone synthesis, secretion and action 💬
 1件: SSTR2 💬 D06495 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
319 Hepatitis B 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
320 Hepatitis C 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
321 Hepatocellular carcinoma 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
322 Hepatocellular carcinoma 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
323 Hepatocellular carcinoma 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
324 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
325 Herpes simplex virus 1 infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
326 Herpes simplex virus 1 infection 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
327 HIF-1 signaling pathway 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
328 HIF-1 signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
329 HIF-1 signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
330 Human cytomegalovirus infection 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
331 Human cytomegalovirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
332 Human cytomegalovirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
333 Human cytomegalovirus infection 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
334 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
335 Human immunodeficiency virus 1 infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
336 Human papillomavirus infection 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
337 Human papillomavirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
338 Human papillomavirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
339 Huntington disease 💬
 1件: CACNA1B 💬 D01173 💬 Cilnidipine 1件: 67 💬
340 Huntington disease 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
341 Huntington disease 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
342 Huntington disease 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
343 Huntington disease 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
344 Hypertrophic cardiomyopathy 💬
 1件: ACE 💬 D08068 💬 Imidapril 1件: 67 💬
345 Hypertrophic cardiomyopathy 💬
 1件: ACE 💬 D00362 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
346 Hypertrophic cardiomyopathy 💬
 1件: ACE 💬 D08131 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
347 Hypertrophic cardiomyopathy 💬
 1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
348 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
349 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
350 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
351 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
352 Hypertrophic cardiomyopathy 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
353 Hypertrophic cardiomyopathy 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
354 Inflammatory mediator regulation of TRP channels 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
355 Insulin resistance 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
356 Insulin resistance 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
357 Insulin resistance 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
358 Insulin resistance 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
359 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
360 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
361 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
362 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
363 Insulin signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
364 Insulin signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
365 Insulin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
366 Insulin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
367 JAK-STAT signaling pathway 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
368 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
369 JAK-STAT signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
370 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
371 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
372 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
373 Lipid and atherosclerosis 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
374 Lipid and atherosclerosis 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
375 Lipid and atherosclerosis 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
376 Long-term potentiation 💬
 1件: CACNA1C 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
377 Long-term potentiation 💬
 1件: CACNA1C 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
378 Long-term potentiation 💬
 1件: CACNA1C 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
379 Long-term potentiation 💬
 1件: CACNA1C 💬 D01173 💬 Cilnidipine 1件: 67 💬
380 Longevity regulating pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
381 Longevity regulating pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
382 Longevity regulating pathway 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
383 Longevity regulating pathway 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
384 Longevity regulating pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
385 Longevity regulating pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
386 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
387 Longevity regulating pathway - multiple species 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
388 Longevity regulating pathway - multiple species 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
389 Longevity regulating pathway - multiple species 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
390 MAPK signaling pathway 💬
 5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
391 MAPK signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
392 MAPK signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
393 MAPK signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
394 MAPK signaling pathway 💬
 4件: EGFR, ERBB2, FLT4, KDR 💬 D11772 💬 Tesevatinib 1件: 67 💬
395 Melanoma 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
396 Metabolic pathways 💬
 1件: AOC3 💬 D08044 💬 Hydralazine 1件: 67 💬
397 Metabolic pathways 💬
 1件: HMGCR 💬 D00893 💬 Pravastatin 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
398 Metabolic pathways 💬
 1件: HMGCR 💬 D08410 💬 Pravastatin 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
399 Metabolic pathways 💬
 1件: UGCG 💬 D11633 💬 Venglustat 3件:  6 , 19, 67 💬
400 MicroRNAs in cancer 💬
 1件: ABL1 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
401 MicroRNAs in cancer 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
402 MicroRNAs in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
403 MicroRNAs in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
404 Mitophagy - animal 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
405 Morphine addiction 💬
 1件: CACNA1B 💬 D01173 💬 Cilnidipine 1件: 67 💬
406 mTOR signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
407 mTOR signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
408 mTOR signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
409 mTOR signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
410 Neuroactive ligand-receptor interaction 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin 2件: 57, 67 💬
411 Neuroactive ligand-receptor interaction 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin 2件: 57, 67 💬
412 Neuroactive ligand-receptor interaction 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
413 Neuroactive ligand-receptor interaction 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
414 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
415 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
416 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
417 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
418 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
419 Neuroactive ligand-receptor interaction 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
420 Neuroactive ligand-receptor interaction 💬
 1件: AVPR2 💬 D04752 💬 Lixivaptan 1件: 67 💬
421 Neuroactive ligand-receptor interaction 💬
 1件: AVPR2 💬 D01213 💬 Tolvaptan 3件: 67, 72, 225 💬
422 Neuroactive ligand-receptor interaction 💬
 5件: SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬 D07431 💬 Somatostatin 2件: 67, 78 💬
423 Neuroactive ligand-receptor interaction 💬
 4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
424 Neuroactive ligand-receptor interaction 💬
 1件: SSTR2 💬 D00442 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
425 Neuroactive ligand-receptor interaction 💬
 1件: SSTR2 💬 D06495 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
426 Neurotrophin signaling pathway 💬
 1件: ABL1 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
427 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
428 Neutrophil extracellular trap formation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
429 Neutrophil extracellular trap formation 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
430 Nicotine addiction 💬
 1件: CACNA1B 💬 D01173 💬 Cilnidipine 1件: 67 💬
431 Non-alcoholic fatty liver disease 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
432 Non-alcoholic fatty liver disease 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
433 Non-alcoholic fatty liver disease 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
434 Non-alcoholic fatty liver disease 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
435 Non-small cell lung cancer 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
436 Osteoclast differentiation 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
437 Osteoclast differentiation 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
438 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
439 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
440 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
441 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
442 Oxytocin signaling pathway 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
443 Oxytocin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
444 Oxytocin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
445 Oxytocin signaling pathway 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
446 Pancreatic cancer 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
447 Pancreatic cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
448 Pancreatic cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
449 Parathyroid hormone synthesis, secretion and action 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
450 Pathogenic Escherichia coli infection 💬
 2件: ABL1, SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
451 Pathways in cancer 💬
 1件: ABL1 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
452 Pathways in cancer 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
453 Pathways in cancer 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
454 Pathways in cancer 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
455 Pathways in cancer 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
456 Pathways in cancer 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
457 Pathways in cancer 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
458 Pathways in cancer 💬
 3件: EGFR, ERBB2, FLT4 💬 D11772 💬 Tesevatinib 1件: 67 💬
459 Pathways in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
460 Pathways in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
461 Pathways in cancer 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
462 Pathways in cancer 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
463 Pathways of neurodegeneration - multiple diseases 💬
 5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
464 Pathways of neurodegeneration - multiple diseases 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
465 Pathways of neurodegeneration - multiple diseases 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
466 Pathways of neurodegeneration - multiple diseases 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
467 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
468 Pathways of neurodegeneration - multiple diseases 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
469 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
470 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
471 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
472 Phenylalanine metabolism 💬
 1件: AOC3 💬 D08044 💬 Hydralazine 1件: 67 💬
473 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
474 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
475 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
476 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
477 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
478 Phospholipase D signaling pathway 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
479 Phospholipase D signaling pathway 💬
 1件: AVPR2 💬 D04752 💬 Lixivaptan 1件: 67 💬
480 Phospholipase D signaling pathway 💬
 1件: AVPR2 💬 D01213 💬 Tolvaptan 3件: 67, 72, 225 💬
481 Phospholipase D signaling pathway 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
482 Phospholipase D signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
483 Phospholipase D signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
484 PI3K-Akt signaling pathway 💬
 4件: EGFR, ERBB2, FLT4, KDR 💬 D11772 💬 Tesevatinib 1件: 67 💬
485 PI3K-Akt signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
486 PI3K-Akt signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
487 PI3K-Akt signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
488 PI3K-Akt signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
489 Platelet activation 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
490 Platinum drug resistance 💬
 1件: ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
491 PPAR signaling pathway 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
492 PPAR signaling pathway 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
493 Prion disease 💬
 5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
494 Prion disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
495 Prion disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
496 Prion disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
497 Prolactin signaling pathway 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
498 Prostate cancer 💬
 2件: EGFR, ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
499 Prostate cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
500 Prostate cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
501 Proteoglycans in cancer 💬
 3件: EGFR, ERBB2, KDR 💬 D11772 💬 Tesevatinib 1件: 67 💬
502 Proteoglycans in cancer 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
503 Proteoglycans in cancer 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
504 Proteoglycans in cancer 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
505 Rap1 signaling pathway 💬
 3件: EGFR, FLT4, KDR 💬 D11772 💬 Tesevatinib 1件: 67 💬
506 Rap1 signaling pathway 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
507 Ras signaling pathway 💬
 1件: ABL1 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
508 Ras signaling pathway 💬
 3件: EGFR, FLT4, KDR 💬 D11772 💬 Tesevatinib 1件: 67 💬
509 Regulation of actin cytoskeleton 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
510 Regulation of actin cytoskeleton 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
511 Regulation of lipolysis in adipocytes 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
512 Regulation of lipolysis in adipocytes 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
513 Relaxin signaling pathway 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
514 Relaxin signaling pathway 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
515 Renin secretion 💬
 1件: ACE 💬 D08068 💬 Imidapril 1件: 67 💬
516 Renin secretion 💬
 1件: ACE 💬 D00362 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
517 Renin secretion 💬
 1件: ACE 💬 D08131 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
518 Renin secretion 💬
 1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
519 Renin secretion 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
520 Renin secretion 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
521 Renin secretion 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
522 Renin secretion 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
523 Renin secretion 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
524 Renin secretion 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
525 Renin secretion 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
526 Renin secretion 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
527 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
528 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
529 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
530 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
531 Renin-angiotensin system 💬
 1件: ACE 💬 D08068 💬 Imidapril 1件: 67 💬
532 Renin-angiotensin system 💬
 1件: ACE 💬 D00362 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
533 Renin-angiotensin system 💬
 1件: ACE 💬 D08131 💬 Lisinopril 7件: 19, 46, 49, 66, 67, 113, 222 💬
534 Renin-angiotensin system 💬
 1件: ACE 💬 D00421 💬 Ramipril 7件: 46, 49, 66, 67, 113, 218, 257 💬
535 Renin-angiotensin system 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
536 Renin-angiotensin system 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
537 Renin-angiotensin system 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
538 Renin-angiotensin system 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
539 Renin-angiotensin system 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
540 Renin-angiotensin system 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
541 Retrograde endocannabinoid signaling 💬
 5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
542 Retrograde endocannabinoid signaling 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
543 Retrograde endocannabinoid signaling 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
544 Retrograde endocannabinoid signaling 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
545 Salivary secretion 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin 2件: 57, 67 💬
546 Salivary secretion 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin 2件: 57, 67 💬
547 Salivary secretion 💬
 1件: ADRB1 💬 D00634 💬 Bisoprolol 3件: 67, 86, 113 💬
548 Salivary secretion 💬
 1件: ADRB1 💬 D02342 💬 Bisoprolol 3件: 67, 86, 113 💬
549 Serotonergic synapse 💬
 5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
550 Serotonergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
551 Serotonergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
552 Serotonergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
553 Shigellosis 💬
 1件: EGFR 💬 D11772 💬 Tesevatinib 1件: 67 💬
554 Shigellosis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
555 Shigellosis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
556 Shigellosis 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
557 Sphingolipid metabolism 💬
 1件: UGCG 💬 D11633 💬 Venglustat 3件:  6 , 19, 67 💬
558 Spinocerebellar ataxia 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
559 Spinocerebellar ataxia 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
560 Synaptic vesicle cycle 💬
 1件: CACNA1B 💬 D01173 💬 Cilnidipine 1件: 67 💬
561 Taste transduction 💬
 1件: CACNA1C 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
562 Taste transduction 💬
 1件: CACNA1C 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
563 Taste transduction 💬
 1件: CACNA1C 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
564 Taste transduction 💬
 1件: CACNA1C 💬 D01173 💬 Cilnidipine 1件: 67 💬
565 Taste transduction 💬
 3件: SCNN1A, SCNN1B, SCNN1G 💬 D00649 💬 Amiloride 4件: 13, 67, 225, 299 💬
566 Taste transduction 💬
 3件: SCNN1A, SCNN1B, SCNN1G 💬 D07447 💬 Amiloride 4件: 13, 67, 225, 299 💬
567 Taste transduction 💬
 2件: TAS1R2, TAS1R3 💬 D02381 💬 Aspartame 5件:  6 , 13, 67, 86, 230 💬
568 Terpenoid backbone biosynthesis 💬
 1件: HMGCR 💬 D00893 💬 Pravastatin 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
569 Terpenoid backbone biosynthesis 💬
 1件: HMGCR 💬 D08410 💬 Pravastatin 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
570 Th17 cell differentiation 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
571 Th17 cell differentiation 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
572 Thermogenesis 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
573 Thermogenesis 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
574 Thermogenesis 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
575 Thermogenesis 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
576 Thermogenesis 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
577 Thermogenesis 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
578 Thyroid cancer 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
579 Thyroid cancer 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
580 Thyroid hormone signaling pathway 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
581 Thyroid hormone signaling pathway 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
582 Thyroid hormone signaling pathway 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
583 Tight junction 💬
 1件: CACNA1D 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
584 Tight junction 💬
 1件: CACNA1D 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
585 Tight junction 💬
 1件: CACNA1D 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
586 Tight junction 💬
 1件: CACNA1D 💬 D01173 💬 Cilnidipine 1件: 67 💬
587 Tight junction 💬
 1件: ERBB2 💬 D11772 💬 Tesevatinib 1件: 67 💬
588 Tight junction 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
589 Tight junction 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 24件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
590 Tight junction 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
591 Transcriptional misregulation in cancer 💬
 1件: PPARG 💬 D00945 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
592 Transcriptional misregulation in cancer 💬
 1件: PPARG 💬 D08378 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
593 Tuberculosis 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
594 Type II diabetes mellitus 💬
 3件: CACNA1B, CACNA1C, CACNA1D 💬 D01173 💬 Cilnidipine 1件: 67 💬
595 Type II diabetes mellitus 💬
 2件: CACNA1C, CACNA1D 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
596 Type II diabetes mellitus 💬
 2件: CACNA1C, CACNA1D 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
597 Type II diabetes mellitus 💬
 2件: CACNA1C, CACNA1D 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
598 Type II diabetes mellitus 💬
 1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
599 Type II diabetes mellitus 💬
 1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
600 Tyrosine metabolism 💬
 1件: AOC3 💬 D08044 💬 Hydralazine 1件: 67 💬
601 Vascular smooth muscle contraction 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin 2件: 57, 67 💬
602 Vascular smooth muscle contraction 💬
 3件: ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin 2件: 57, 67 💬
603 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D00522 💬 Candesartan 2件: 58, 67 💬
604 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D00522 💬 Candesartan cilexetil 1件: 67 💬
605 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D00626 💬 Candesartan cilexetil 1件: 67 💬
606 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
607 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
608 Vascular smooth muscle contraction 💬
 1件: AGTR1 💬 D00627 💬 Telmisartan 2件: 66, 67 💬
609 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine 4件: 13, 51, 67, 298 💬
610 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine 4件: 13, 51, 67, 298 💬
611 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine 4件: 13, 51, 67, 298 💬
612 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine 1件: 67 💬
613 Vasopressin-regulated water reabsorption 💬
 1件: AVPR2 💬 D04752 💬 Lixivaptan 1件: 67 💬
614 Vasopressin-regulated water reabsorption 💬
 1件: AVPR2 💬 D01213 💬 Tolvaptan 3件: 67, 72, 225 💬
615 VEGF signaling pathway 💬
 1件: KDR 💬 D11772 💬 Tesevatinib 1件: 67 💬
616 VEGF signaling pathway 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
617 Viral carcinogenesis 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
618 Viral myocarditis 💬
 1件: ABL1 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬
619 Yersinia infection 💬
 1件: SRC 💬 D03252 💬 Bosutinib 2件:  2 , 67 💬

先頭へ